TITLE

Patient compliance with phlebotomy therapy for iron overload associated with hemochromatosis

AUTHOR(S)
Hicken, Bret L.; Tucker, Diane C.; Barton, James C.
PUB. DATE
September 2003
SOURCE
American Journal of Gastroenterology;Sep2003, Vol. 98 Issue 9, p2072
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
: ObjectiveThe aim of this study was to evaluate patient compliance with phlebotomy therapy of hemochromatosis-associated iron overload.: MethodsWe reviewed medical records of white adults with hemochromatosis and iron overload diagnosed during medical care. We defined three elements of compliance: 1) achieving iron depletion (serum ferritin ≤ 20 ng/ml); 2) timeliness of phlebotomies on a weekly or biweekly schedule to achieve iron depletion; and 3) participation in therapy to maintain serum ferritin ≤ 50 ng/ml. We evaluated associations of timeliness of phlebotomy and participation in maintenance therapy with these variables: age at diagnosis, sex, pretreatment serum ferritin concentration, HFE genotype, units of blood removed to achieve iron depletion, and presence or absence of cirrhosis at diagnosis.: ResultsA total of 118 patients were evaluable for iron depletion and 142 for maintenance therapy; 96.6% achieved iron depletion, and 33.1% and 43.2% followed weekly and biweekly schedules, respectively. Timeliness was not significantly associated with the variables we evaluated. In the first year of maintenance therapy, 84.0% of patients complied; the percentage of C282Y homozygotes complying was significantly greater than that of other patients. Average compliance with maintenance therapy decreased 6.8% annually; the mean follow-up after achieving iron depletion was 4.1 ± 2.8 yr (range 0.6–9.7 yr).: ConclusionsMost patients with hemochromatosis diagnosed in medical care achieve iron depletion with phlebotomy; one-third tolerate and adhere to weekly phlebotomy. There is a constant rate of decline in the percentage of patients who comply with maintenance therapy.
ACCESSION #
10807812

 

Related Articles

  • Discarded blood could be put to good use, say experts. Brown, Edwin W. // Medical Update;Dec97, Vol. 21 Issue 6, p1 

    Focuses on `therapeutic phlebotomies' for hemochromatosis, or the iron overload disease, a hereditary medical condition for which the treatment is regular bloodletting. Early warning signs of the disease; Comment of many hematologist about the safety of blood from people with hemochromatosis. ...

  • Diagnosis of juvenile hemochromatosis in an 11-year-old child combining genetic analysis and non-invasive liver iron quantitation. De Gobbi, M.; Caruso, R.; Daraio, F.; Chianale, F.; Pinto, R. M.; Longo, F.; Piga, A.; Camaschella, C. // European Journal of Pediatrics;2003, Vol. 162 Issue 2, p96 

    Describes methods for the diagnosis of juvenile hemochromatosis in an 11-year-old child combining genetic analysis and non-invasive liver iron quantitation. Treatment in presymptomatic stages to prevent organ damage; Reduction of iron overlaod through a regular phlebotomy protocol to prevent...

  • Evidence for the High Importance of Co-Morbid Factors in HFE C282Y/H63D Patients Cared by Phlebotomies: Results from an Observational Prospective Study. Saliou, Philippe; Le Gac, Gérald; Mercier, Anne-Yvonne; Chanu, Brigitte; Guéguen, Paul; Mérour, Marie-Christine; Gourlaouen, Isabelle; Autret, Sandrine; Le Maréchal, Cédric; Rouault, Karen; Nousbaum, Jean-Baptiste; Férec, Claude; Scotet, Virginie // PLoS ONE;Dec2013, Vol. 8 Issue 12, p1 

    Despite type I haemochromatosis (HC) is mainly associated with the HFE C282Y/C282Y genotype, a second genotype -C282Y/H63D- has mostly been described in other patients. Its association with HC, apart from any associated co-morbid factors, remains unclear and complex to interpret for physicians....

  • A routine check-up reveals a significant genetic abnormality. BEYER BLODGET, JILL // Clinical Advisor;Apr2012, Vol. 15 Issue 4, p77 

    The article presents a case study of a 37-year-old male who went for a routine physical examination as part of his employer's incentive pay program. Upon blood examination, it reveals that his alanine transaminase (ALT) level has elevated at 45 units per liter (U/L). Further tests has been...

  • Haemochromatosis: the role of the HCA and the AP in tackling iron overload. Peate, Ian // British Journal of Healthcare Assistants;Jul2014, Vol. 8 Issue 7, p328 

    This article provides the healthcare assistant and assistant practitioner (HCA and AP) with an overview of the genetic (inherited) condition, haemochromatosis, sometimes called ‘iron overload’. It is sometimes difficult to make a diagnosis of haemochromatosis, as the signs and...

  • Osteoporosis in Hemochromatosis: Iron Excess, Gonadal Deficiency, or Other Factors? Diamond, Terrence; Stiel, Daniel; Posen, Solomon // Annals of Internal Medicine;3/15/89, Vol. 110 Issue 6, p430 

    Defines the prevalence, severity, type and pathogenesis of osteopenia in idiopathic hemochromatosis. Basis for the diagnosis of the patients; Determination of serum chemical variables; Measurement of vertebral bone density; Effect of long-term phlebotomy on vitamin D status and dynamic skeletal...

  • Erythrocyte ferritin content in idiopathic haemochromatosis and alcoholic liver disease with iron overload. van der Weyden, Martin B.; Fong, Hubert; Salem, Hatem H.; Batey, Robert G.; Dudley, Frank J. // British Medical Journal (Clinical Research Edition);3/5/1983, Vol. 286 Issue 6367, p752 

    Focuses on the measurement of erythrocyte ferritin contents in patients with idiopathic hemochromatosis and alcoholic liver disease with iron overload. Influence of phlebotomy in the increase of red cell ferritin; Characterization of idiopathic hemochromatosis; Molecular mechanisms for iron...

  • HEMOCHROMATOSIS AND HEART FAILURE: PRESENTATION OF A CASE WITH SURVIVAL AFTER THREE YEARS' TREATMENT BY REPEATED VENESECTION. Grosberg, Saul J. // Annals of Internal Medicine;Mar61, Vol. 54 Issue 3, p550 

    Presents the unusual feature of a patient's survival in a state of continuing good health three years after the onset of heart failure, and whose hemochromatosis responded dramatically to a plan of repeated venesection. Theoretic explanations for the objective and subjective improvement...

  • Homozygosity for Hemochromatosis: Clinical Manifestations. Edwards, Corwin Q.; Cartwright, George E.; Skolnick, Mark H.; Bernard Amos, D. // Annals of Internal Medicine;Oct80, Vol. 93 Issue 4, p519 

    Presents a study which described clinical and laboratory manifestations in hemochromatosis homozygotes. Characteristics of hemochromatosis; Methods used; Symptoms and signs of hemochromatosis at time of diagnosis; Alterations in iron status during phlebotomy.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics